<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="recognize">
            <roleset id="recognize.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="agent&#x0A;" />
                    <role n="1" descr="thing being identified&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle was recognized by Anti-64kD human autoantigen D1 antibodies.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>A approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle was recognized by Anti-64kD human autoantigen D1 antibodies.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>Anti-64kD human autoantigen D1 antibodies recognized specifically a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>Epitopes in the C-terminus of LMP-1 at a 1:200 dilution are recognized by affinity-purified polyclonal anti-LMP-1 antiserum that blots were probed with.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Epitopes in the C-terminus of LMP-1 at a 1:200 dilution are recognized by affinity-purified polyclonal anti-LMP-1 antiserum that blots were probed with.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters, and multiple alignments of binding sites for a number of regulators have shown that the proteins are able to recognize short motifs within the protected region.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters, and multiple alignments of binding sites for a number of regulators have shown that the proteins are able to recognize short motifs within the protected region.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>The C-terminus of CD40 at a 1:500 dilution is recognized by rabbit polyclonal anti-CD40 antiserum that blots were probed with.</text>
                    <arg n="0">rabbit polyclonal anti-CD40 antiserum</arg>
                    <arg n="1">C-terminus of CD40 at a 1:500 dilution</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>These mutations, identified by standard methods of reverse transcription, PCR,dideoxy-chain termination, and cycle sequencing, alter highly conserved sequences at intron/exon boundaries and cause the normal splice junction not to be properly recognized by the RNA-splicing apparatus.</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the normal splice junction</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>We show that the cAMP-CRP activator complex has recognized two sites in tsx-p2 that are separated by 33 bp : a high-affinity site (CRP-1) overlaps the-35 region, and a low-affinity site (CRP-2) is centered around position-74 bp.</text>
                    <arg n="0">the cAMP-CRP activator complex</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="GREC" no="1">
                    <text>The eukaryotic upstream binding factor (UBF), recognizes the ribosomal RNA gene promoter and activates transcription mediated by RNA polymerase I through cooperative interactions with the species-specific factor, SL1.</text>
                    <arg n="0">The eukaryotic upstream binding factor (UBF)</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="MEDLINE" no="1">
                    <text>A number of Ags recognized by class I-restricted melanoma-specific T cells have recently been isolated, raising the hope that this will lead to the development of improved therapies.</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">A number of Ags</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle is recognized by The eukaryotic upstream binding factor (UBF).</text>
                    <arg n="0">The eukaryotic upstream binding factor (UBF)</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>A approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle was recognized by the proteins.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>A approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle will be recognized by The NarL protein.</text>
                    <arg n="0">The NarL protein</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>A monoclonal antibody have recognized the STAT1 N-terminus in the regulated promoters.</text>
                    <arg n="0">A monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>A monoclonal antibody recognized specifically the STAT1 N-terminus.</text>
                    <arg n="0">A monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>A monoclonal antibody will recognize the STAT1 N-terminus in the regulated promoters.</text>
                    <arg n="0">A monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>A monoclonal antibody, has recognized the ribosomal RNA gene promoter and activated transcription mediated by RNA polymerase I through cooperative interactions with the species-specific factor, SL1.</text>
                    <arg n="0">A monoclonal antibody</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Affinity-purified polyclonal anti-LMP-1 antiserum recognized a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Affinity-purified polyclonal anti-LMP-1 antiserum recognized multiple binding sites.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">multiple binding sites</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Affinity-purified polyclonal anti-LMP-1 antiserum recognizes multiple binding sites.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">multiple binding sites</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Anti-64kD human autoantigen D1 antibodies also binds to these 7-2-7 sites but, unlike NarP, also recognizes a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Anti-64kD human autoantigen D1 antibodies which recognizes a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle is purchased from Transduction Laboratories (Lexington, KY).</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>Anti-64kD human autoantigen D1 antibodies will recognize a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle in the regulated promoters.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>Anti-64kD human autoantigen D1 antibodies will recognize a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle in the regulated promoters.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>Anti-64kD human autoantigen D1 antibodies will recognize a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle in the regulated promoters.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>Anti-64kD human autoantigen D1 antibodies, recognized the ribosomal RNA gene promoter and activated transcription mediated by RNA polymerase I through cooperative interactions with the species-specific factor, SL1.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>Blots were probed with a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) recognizing sequence(YPYDVPDYA) at a 1:500 dilution.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>Blots were probed with a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) that can recognize sequence(YPYDVPDYA) at a 1:500 dilution.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>Blots were probed with a monoclonal antibody that can recognize the STAT1 N-terminus.</text>
                    <arg n="0">a monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>Blots were probed with affinity-purified polyclonal anti-LMP-1 antiserum that recognizes the epitopes in the C-terminus of LMP-1 at a 1:200 dilution, or with rabbit polyclonal anti-GFP or anti-RFP (Clontech) antiserum at a 1:250 dilution.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>Blots were probed with anti-Stat3 pAb that recognizes the The lower form of Stat3, Stat3Beta, or with rabbit polyclonal anti-GFP or anti-RFP (Clontech) antiserum at a 1:250 dilution.</text>
                    <arg n="0">anti-Stat3 pAb</arg>
                    <arg n="1">The lower form of Stat3, Stat3Beta</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>Blots were probed with the cAMP-CRP activator complex that can recognize two sites in tsx-p2.</text>
                    <arg n="0">the cAMP-CRP activator complex</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>Blots were probed with the proteins that recognizes the short motifs within the protected region, or with rabbit polyclonal anti-GFP or anti-RFP (Clontech) antiserum at a 1:250 dilution.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>Blots were probed with this antibody in PKR+/+MEFs that can recognize The two forms of Stat3 (Stat3fm and Stat3sm).</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>Blots were probed with this antibody in PKR+/+MEFs that recognizes the The two forms of Stat3 (Stat3fm and Stat3sm), or with rabbit polyclonal anti-GFP or anti-RFP (Clontech) antiserum at a 1:250 dilution.</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>Blots were probed with this antibody in PKR+/+MEFs that recognizes the The two forms of Stat3 (Stat3fm and Stat3sm), or with rabbit polyclonal anti-GFP or anti-RFP (Clontech) antiserum at a 1:250 dilution.</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>C-terminus of CD40 at a 1:500 dilution that are recognized by rabbit polyclonal anti-CD40 antiserum are indicated.</text>
                    <arg n="0">rabbit polyclonal anti-CD40 antiserum</arg>
                    <arg n="1">C-terminus of CD40 at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>C-terminus of CD40 at a 1:500 dilution that will be recognized by rabbit polyclonal anti-CD40 antiserum are indicated.</text>
                    <arg n="0">rabbit polyclonal anti-CD40 antiserum</arg>
                    <arg n="1">C-terminus of CD40 at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>C-terminus of CD40 at a 1:500 dilution were recognized by rabbit polyclonal anti-CD40 antiserum.</text>
                    <arg n="0">rabbit polyclonal anti-CD40 antiserum</arg>
                    <arg n="1">C-terminus of CD40 at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>C-terminus of CD40 at a 1:500 dilution which can be recognized by rabbit polyclonal anti-CD40 antiserum are indicated.</text>
                    <arg n="0">rabbit polyclonal anti-CD40 antiserum</arg>
                    <arg n="1">C-terminus of CD40 at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>C-terminus of CD40 at a 1:500 dilution, is not recognized in the immunoprecipitaiton with rabbit polyclonal anti-CD40 antiserum as it is raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">rabbit polyclonal anti-CD40 antiserum</arg>
                    <arg n="1">C-terminus of CD40 at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>Epitopes in the C-terminus of LMP-1 at a 1:200 dilution are recognized by anti-Stat3 pAb that blots were probed with.</text>
                    <arg n="0">anti-Stat3 pAb</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>Footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters, and multiple alignments of binding sites for a number of regulators have shown that The eukaryotic upstream binding factor (UBF) can recognize The ribosomal RNA gene promoter.</text>
                    <arg n="0">The eukaryotic upstream binding factor (UBF)</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>Footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters, and multiple alignments of binding sites for a number of regulators have shown that a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) can recognize sequence(YPYDVPDYA) at a 1:500 dilution.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>Footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters, and multiple alignments of binding sites for a number of regulators have shown that a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) recognized sequence(YPYDVPDYA) at a 1:500 dilution.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>Footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters, and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody recognized the STAT1 N-terminus.</text>
                    <arg n="0">a monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>Footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters, and multiple alignments of binding sites for a number of regulators have shown that this antibody in PKR+/+MEFs are able to recognize The two forms of Stat3 (Stat3fm and Stat3sm).</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>Footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters, and multiple alignments of binding sites for a number of regulators have shown that this antibody in PKR+/+MEFs are able to recognize The two forms of Stat3 (Stat3fm and Stat3sm).</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>Individual cell clones were analyzed for STAT1 expression by immunofluorescence where a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle were recognized by Anti-64kD human autoantigen D1 antibodies.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>Individual cell clones were analyzed for STAT1 expression by immunofluorescence where short motifs within the protected region were recognized by the proteins.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>Individual cell clones were analyzed for STAT1 expression by immunofluorescence where the different nonmuscle myosin heavy chain isoforms (A and B) are recognized by four different specific antibodies.</text>
                    <arg n="0">four different specific antibodies</arg>
                    <arg n="1">the different nonmuscle myosin heavy chain isoforms (A and B)</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>Individual cell clones were analyzed for STAT1 expression by immunofluorescence with affinity-purified polyclonal anti-LMP-1 antiserum which recognizes epitopes in the C-terminus of LMP-1 at a 1:200 dilution, and by western blotting</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>Individual cell clones were analyzed for STAT1 expression by immunofluorescence with four different specific antibodies recognizing the different nonmuscle myosin heavy chain isoforms (A and B), and by western blotting.</text>
                    <arg n="0">four different specific antibodies</arg>
                    <arg n="1">the different nonmuscle myosin heavy chain isoforms (A and B)</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>Individual cell clones were analyzed for STAT1 expression by immunofluorescence with this antibody in PKR+/+MEFs which recognized The two forms of Stat3 (Stat3fm and Stat3sm), and by western blotting</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>Most regulators belonging to the AraC/XylS family also binds to these 7-2-7 sites but, unlike NarP, also recognizes multiple binding sites.</text>
                    <arg n="0">Most regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">multiple binding sites</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>Most regulators belonging to the AraC/XylS family, has recognized the ribosomal RNA gene promoter and activated transcription mediated by RNA polymerase I through cooperative interactions with the species-specific factor, SL1.</text>
                    <arg n="0">Most regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>The STAT1 N-terminus are recognized by Anti-64kD human autoantigen D1 antibodies purchasing from Transduction Laboratories (Lexington, KY).</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>The STAT1 N-terminus are recognized by this antibody in PKR+/+MEFs purchasing from Transduction Laboratories (Lexington, KY).</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>The eukaryotic upstream binding factor (UBF) also binds to these 7-2-7 sites but, unlike NarP, also recognizes The ribosomal RNA gene promoter.</text>
                    <arg n="0">The eukaryotic upstream binding factor (UBF)</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>The eukaryotic upstream binding factor (UBF) also binds to these 7-2-7 sites but, unlike NarP, also recognizes The ribosomal RNA gene promoter.</text>
                    <arg n="0">The eukaryotic upstream binding factor (UBF)</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>The eukaryotic upstream binding factor (UBF) also binds to these 7-2-7 sites but, unlike NarP, also recognizes The ribosomal RNA gene promoter.</text>
                    <arg n="0">The eukaryotic upstream binding factor (UBF)</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>The short motifs within the protected region is recognized by the proteins that blots were probed with.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>The the different nonmuscle myosin heavy chain isoforms (A and B) is recognized by four different specific antibodies that blots were probed with.</text>
                    <arg n="0">four different specific antibodies</arg>
                    <arg n="1">the different nonmuscle myosin heavy chain isoforms (A and B)</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>The two forms of Stat3 (Stat3fm and Stat3sm), has not been recognized in the immunoprecipitaiton with this antibody in PKR+/+MEFs as it was raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>The two forms of Stat3 (Stat3fm and Stat3sm), was not recognized in the immunoprecipitaiton with this antibody in PKR+/+MEFs as it was raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>The two sites in tsx-p2 is recognized by the cAMP-CRP activator complex that blots were probed with.</text>
                    <arg n="0">the cAMP-CRP activator complex</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>These bands can be detected with A monoclonal antibody which have recognized the STAT1 N-terminus</text>
                    <arg n="0">A monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>These bands can be detected with Anti-64kD human autoantigen D1 antibodies which recognize a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>These bands can be detected with The NarL protein recognizing heptamers in other arrangements</text>
                    <arg n="0">The NarL protein</arg>
                    <arg n="1">heptamers in other arrangements</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>These bands can be detected with a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) that recognized sequence(YPYDVPDYA) at a 1:500 dilution</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>These bands can be detected with affinity-purified polyclonal anti-LMP-1 antiserum which recognize epitopes in the C-terminus of LMP-1 at a 1:200 dilution</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>These bands can be detected with rabbit polyclonal anti-CD40 antiserum that recognized C-terminus of CD40 at a 1:500 dilution</text>
                    <arg n="0">rabbit polyclonal anti-CD40 antiserum</arg>
                    <arg n="1">C-terminus of CD40 at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>We show that Most regulators belonging to the AraC/XylS family recognizes multiple binding sites that are separated by 33 bp : a high-affinity site (CRP-1) overlaps the-35 region, and a low-affinity site (CRP-2) is centered around position-74 bp.</text>
                    <arg n="0">Most regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">multiple binding sites</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>We show that The NarL protein will recognize heptamers in other arrangements that are separated by 33 bp : a high-affinity site (CRP-1) overlaps the-35 region, and a low-affinity site (CRP-2) is centered around position-74 bp.</text>
                    <arg n="0">The NarL protein</arg>
                    <arg n="1">heptamers in other arrangements</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>We show that a monoclonal antibody recognized the STAT1 N-terminus that are separated by 33 bp : a high-affinity site (CRP-1) overlaps the-35 region, and a low-affinity site (CRP-2) is centered around position-74 bp.</text>
                    <arg n="0">a monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>We show that affinity-purified polyclonal anti-LMP-1 antiserum recognizes epitopes in the C-terminus of LMP-1 at a 1:200 dilution that are separated by 33 bp : a high-affinity site (CRP-1) overlaps the-35 region, and a low-affinity site (CRP-2) is centered around position-74 bp.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>We show that four different specific antibodies has recognized the different nonmuscle myosin heavy chain isoforms (A and B) that are separated by 33 bp : a high-affinity site (CRP-1) overlaps the-35 region, and a low-affinity site (CRP-2) is centered around position-74 bp.</text>
                    <arg n="0">four different specific antibodies</arg>
                    <arg n="1">the different nonmuscle myosin heavy chain isoforms (A and B)</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) also binds to these 7-2-7 sites but, unlike NarP, also recognizes sequence(YPYDVPDYA) at a 1:500 dilution.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) also binds to these 7-2-7 sites but, unlike NarP, also recognizes sequence(YPYDVPDYA) at a 1:500 dilution.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) also bound to these 7-2-7 sites but, unlike NarP, also recognized sequence(YPYDVPDYA) at a 1:500 dilution.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) can recognize sequence(YPYDVPDYA) at a 1:500 dilution in the regulated promoters.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) recognized specifically sequence(YPYDVPDYA) at a 1:500 dilution.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim), has recognized the ribosomal RNA gene promoter and activated transcription mediated by RNA polymerase I through cooperative interactions with the species-specific factor, SL1.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle, cannot be recognized in the immunoprecipitaiton with Anti-64kD human autoantigen D1 antibodies as it is raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle, could not be recognized in the immunoprecipitaiton with Anti-64kD human autoantigen D1 antibodies as it was raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle, will not be recognized in the immunoprecipitaiton with Anti-64kD human autoantigen D1 antibodies as it is raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>a monoclonal antibody recognized the STAT1 N-terminus in the regulated promoters.</text>
                    <arg n="0">a monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>affinity-purified polyclonal anti-LMP-1 antiserum have recognized epitopes in the C-terminus of LMP-1 at a 1:200 dilution in the regulated promoters.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>affinity-purified polyclonal anti-LMP-1 antiserum, recognized the ribosomal RNA gene promoter and activated transcription mediated by RNA polymerase I through cooperative interactions with the species-specific factor, SL1.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>anti-Stat3 pAb also bound to these 7-2-7 sites but, unlike NarP, also recognized The lower form of Stat3, Stat3Beta.</text>
                    <arg n="0">anti-Stat3 pAb</arg>
                    <arg n="1">The lower form of Stat3, Stat3Beta</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>anti-Stat3 pAb, will recognize the ribosomal RNA gene promoter and activate transcription mediated by RNA polymerase I through cooperative interactions with the species-specific factor, SL1.</text>
                    <arg n="0">anti-Stat3 pAb</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>epitopes in the C-terminus of LMP-1 at a 1:200 dilution that are recognized by affinity-purified polyclonal anti-LMP-1 antiserum are indicated.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>epitopes in the C-terminus of LMP-1 at a 1:200 dilution which were recognized by affinity-purified polyclonal anti-LMP-1 antiserum are indicated.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>epitopes in the C-terminus of LMP-1 at a 1:200 dilution, cannot be recognized in the immunoprecipitaiton with affinity-purified polyclonal anti-LMP-1 antiserum as it is raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>epitopes in the C-terminus of LMP-1 at a 1:200 dilution, has not been recognized in the immunoprecipitaiton with affinity-purified polyclonal anti-LMP-1 antiserum as it was raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">affinity-purified polyclonal anti-LMP-1 antiserum</arg>
                    <arg n="1">epitopes in the C-terminus of LMP-1 at a 1:200 dilution</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>four different specific antibodies also binds to these 7-2-7 sites but, unlike NarP, also recognizes the different nonmuscle myosin heavy chain isoforms (A and B).</text>
                    <arg n="0">four different specific antibodies</arg>
                    <arg n="1">the different nonmuscle myosin heavy chain isoforms (A and B)</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>four different specific antibodies recognize specifically the different nonmuscle myosin heavy chain isoforms (A and B).</text>
                    <arg n="0">four different specific antibodies</arg>
                    <arg n="1">the different nonmuscle myosin heavy chain isoforms (A and B)</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>four different specific antibodies recognized specifically the different nonmuscle myosin heavy chain isoforms (A and B).</text>
                    <arg n="0">four different specific antibodies</arg>
                    <arg n="1">the different nonmuscle myosin heavy chain isoforms (A and B)</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>heptamers in other arrangements which were recognized by The NarL protein are indicated.</text>
                    <arg n="0">The NarL protein</arg>
                    <arg n="1">heptamers in other arrangements</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>multiple binding sites are recognized by Most regulators belonging to the AraC/XylS family.</text>
                    <arg n="0">Most regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">multiple binding sites</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>multiple binding sites recognized by Most regulators belonging to the AraC/XylS family are indicated.</text>
                    <arg n="0">Most regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">multiple binding sites</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>multiple binding sites that were recognized by Most regulators belonging to the AraC/XylS family are indicated.</text>
                    <arg n="0">Most regulators belonging to the AraC/XylS family</arg>
                    <arg n="1">multiple binding sites</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>rabbit polyclonal anti-CD40 antiserum has also bound to these 7-2-7 sites but, unlike NarP, has also recognized C-terminus of CD40 at a 1:500 dilution.</text>
                    <arg n="0">rabbit polyclonal anti-CD40 antiserum</arg>
                    <arg n="1">C-terminus of CD40 at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>rabbit polyclonal anti-CD40 antiserum recognizing C-terminus of CD40 at a 1:500 dilution was purchased from Transduction Laboratories (Lexington, KY).</text>
                    <arg n="0">rabbit polyclonal anti-CD40 antiserum</arg>
                    <arg n="1">C-terminus of CD40 at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>rabbit polyclonal anti-CD40 antiserum, will recognize the ribosomal RNA gene promoter and activate transcription mediated by RNA polymerase I through cooperative interactions with the species-specific factor, SL1.</text>
                    <arg n="0">rabbit polyclonal anti-CD40 antiserum</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>sequence(YPYDVPDYA) at a 1:500 dilution that were recognized by a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) are indicated.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>sequence(YPYDVPDYA) at a 1:500 dilution, cannot be recognized in the immunoprecipitaiton with a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim) as it is raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">sequence(YPYDVPDYA) at a 1:500 dilution</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>short motifs within the protected region that will be recognized by the proteins are indicated.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>short motifs within the protected region that will be recognized by the proteins are indicated.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>short motifs within the protected region which can be recognized by the proteins are indicated.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>short motifs within the protected region, has not been recognized in the immunoprecipitaiton with the proteins as it was raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>short motifs within the protected region, will not be recognized in the immunoprecipitaiton with the proteins as it is raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>the STAT1 N-terminus that are recognized by a monoclonal antibody are indicated.</text>
                    <arg n="0">a monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>the STAT1 N-terminus that were recognized by a monoclonal antibody are indicated.</text>
                    <arg n="0">a monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>the STAT1 N-terminus, was not recognized in the immunoprecipitaiton with A monoclonal antibody as it was raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">A monoclonal antibody</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>the cAMP-CRP activator complex will recognize two sites in tsx-p2 in the regulated promoters.</text>
                    <arg n="0">the cAMP-CRP activator complex</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>the different nonmuscle myosin heavy chain isoforms (A and B), cannot be recognized in the immunoprecipitaiton with four different specific antibodies as it is raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">four different specific antibodies</arg>
                    <arg n="1">the different nonmuscle myosin heavy chain isoforms (A and B)</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>the proteins recognized specifically short motifs within the protected region.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">short motifs within the protected region</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>the ribosomal RNA gene promoter is recognized by Anti-64kD human autoantigen D1 antibodies.</text>
                    <arg n="0">Anti-64kD human autoantigen D1 antibodies</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>the ribosomal RNA gene promoter is recognized by the proteins.</text>
                    <arg n="0">the proteins</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>the ribosomal RNA gene promoter was recognized by a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim).</text>
                    <arg n="0">a RAT monoclonal anti-HA antibody (Boehringer-Ingelheim)</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>the ribosomal RNA gene promoter was recognized by anti-Stat3 pAb.</text>
                    <arg n="0">anti-Stat3 pAb</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>the ribosomal RNA gene promoter was recognized by this antibody in PKR+/+MEFs.</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>this antibody in PKR+/+MEFs are able to recognize The two forms of Stat3 (Stat3fm and Stat3sm) in the regulated promoters.</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>this antibody in PKR+/+MEFs recognize The two forms of Stat3 (Stat3fm and Stat3sm) in the regulated promoters.</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>this antibody in PKR+/+MEFs will recognize The two forms of Stat3 (Stat3fm and Stat3sm) in the regulated promoters.</text>
                    <arg n="0">this antibody in PKR+/+MEFs</arg>
                    <arg n="1">The two forms of Stat3 (Stat3fm and Stat3sm)</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>two sites in tsx-p2, is not recognized in the immunoprecipitaiton with the cAMP-CRP activator complex as it is raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">the cAMP-CRP activator complex</arg>
                    <arg n="1">two sites in tsx-p2</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle has been recognized by either of two monoclonal antibodies.</text>
                    <arg n="0">either of two monoclonal antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle has been recognized by the RNA-splicing apparatus.</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle has been recognized by the autologous serum.</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>A approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle is recognized by either of two monoclonal antibodies.</text>
                    <arg n="0">either of two monoclonal antibodies</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>A approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle will be recognized by the RNA-splicing apparatus.</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">a approximately 70kD polypeptide in western blots of extraocular muscle, sternothyroid muscle, and smooth muscle</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>A number of Ags that are recognized by class I-restricted melanoma-specific T cells are indicated.</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">A number of Ags</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>Blots were probed with class I-restricted melanoma-specific T cells that recognized A number of Ags.</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">A number of Ags</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Blots were probed with class I-restricted melanoma-specific T cells that recognized A number of Ags.</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">A number of Ags</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Blots were probed with class I-restricted melanoma-specific T cells that recognized A number of Ags.</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">A number of Ags</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Blots were probed with either of two monoclonal antibodies that recognized COOH-terminal epitopes.</text>
                    <arg n="0">either of two monoclonal antibodies</arg>
                    <arg n="1">COOH-terminal epitopes</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>Blots were probed with the RNA-splicing apparatus recognizing the normal splice junction.</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the normal splice junction</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>Blots were probed with the RNA-splicing apparatus that can recognize the normal splice junction.</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the normal splice junction</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>Blots were probed with the RNA-splicing apparatus that recognizes the the normal splice junction, or with rabbit polyclonal anti-GFP or anti-RFP (Clontech) antiserum at a 1:250 dilution.</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the normal splice junction</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>Blots were probed with the autologous serum recognizing the epitopes.</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">the epitopes</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>COOH-terminal epitopes recognized by either of two monoclonal antibodies are indicated.</text>
                    <arg n="0">either of two monoclonal antibodies</arg>
                    <arg n="1">COOH-terminal epitopes</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>Footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters, and multiple alignments of binding sites for a number of regulators have shown that the autologous serum recognized the epitopes.</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">the epitopes</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Individual cell clones were analyzed for STAT1 expression by immunofluorescence with the RNA-splicing apparatus which recognized the normal splice junction, and by western blotting</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the normal splice junction</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>The COOH-terminal epitopes is recognized by either of two monoclonal antibodies that blots were probed with.</text>
                    <arg n="0">either of two monoclonal antibodies</arg>
                    <arg n="1">COOH-terminal epitopes</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>The STAT1 N-terminus are recognized by the autologous serum purchasing from Transduction Laboratories (Lexington, KY).</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>The STAT1 N-terminus were recognized by the RNA-splicing apparatus purchasing from Transduction Laboratories (Lexington, KY).</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the STAT1 N-terminus</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>These bands can be detected with class I-restricted melanoma-specific T cells that recognize A number of Ags</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">A number of Ags</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>These bands can be detected with the RNA-splicing apparatus which have recognized the normal splice junction</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the normal splice junction</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>These bands can be detected with the autologous serum which recognize the epitopes</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">the epitopes</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>We show that class I-restricted melanoma-specific T cells will recognize A number of Ags that are separated by 33 bp : a high-affinity site (CRP-1) overlaps the-35 region, and a low-affinity site (CRP-2) is centered around position-74 bp.</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">A number of Ags</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>class I-restricted melanoma-specific T cells also bound to these 7-2-7 sites but, unlike NarP, also recognized A number of Ags.</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">A number of Ags</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>class I-restricted melanoma-specific T cells have recognized A number of Ags in the regulated promoters.</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">A number of Ags</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>class I-restricted melanoma-specific T cells will binds to these 7-2-7 sites but, unlike NarP, will also recognize A number of Ags.</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">A number of Ags</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>either of two monoclonal antibodies are able to recognize COOH-terminal epitopes in the regulated promoters.</text>
                    <arg n="0">either of two monoclonal antibodies</arg>
                    <arg n="1">COOH-terminal epitopes</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>either of two monoclonal antibodies recognize COOH-terminal epitopes in the regulated promoters.</text>
                    <arg n="0">either of two monoclonal antibodies</arg>
                    <arg n="1">COOH-terminal epitopes</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>the RNA-splicing apparatus also binds to these 7-2-7 sites but, unlike NarP, also recognizes the normal splice junction.</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the normal splice junction</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>the RNA-splicing apparatus which has recognized the normal splice junction was purchased from Transduction Laboratories (Lexington, KY).</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the normal splice junction</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>the RNA-splicing apparatus, recognizes the ribosomal RNA gene promoter and activates transcription mediated by RNA polymerase I through cooperative interactions with the species-specific factor, SL1.</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>the epitopes that are recognized by the autologous serum are indicated.</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">the epitopes</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>the epitopes that were recognized by the autologous serum are indicated.</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">the epitopes</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>the epitopes were recognized by the autologous serum.</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">the epitopes</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>the epitopes which can be recognized by the autologous serum are indicated.</text>
                    <arg n="0">the autologous serum</arg>
                    <arg n="1">the epitopes</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>the normal splice junction that will be recognized by the RNA-splicing apparatus are indicated.</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the normal splice junction</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>the normal splice junction, cannot be recognized in the immunoprecipitaiton with the RNA-splicing apparatus as it is raised against a C-terminal region of Stat3 that is missing in Stat3Beta.</text>
                    <arg n="0">the RNA-splicing apparatus</arg>
                    <arg n="1">the normal splice junction</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>the ribosomal RNA gene promoter is recognized by either of two monoclonal antibodies.</text>
                    <arg n="0">either of two monoclonal antibodies</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>the ribosomal RNA gene promoter was recognized by class I-restricted melanoma-specific T cells.</text>
                    <arg n="0">class I-restricted melanoma-specific T cells</arg>
                    <arg n="1">The ribosomal RNA gene promoter</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
